| pubmed-article:16896954 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16896954 | lifeskim:mentions | umls-concept:C0237798 | lld:lifeskim |
| pubmed-article:16896954 | lifeskim:mentions | umls-concept:C0031268 | lld:lifeskim |
| pubmed-article:16896954 | lifeskim:mentions | umls-concept:C0006104 | lld:lifeskim |
| pubmed-article:16896954 | lifeskim:mentions | umls-concept:C0132800 | lld:lifeskim |
| pubmed-article:16896954 | lifeskim:mentions | umls-concept:C0076823 | lld:lifeskim |
| pubmed-article:16896954 | lifeskim:mentions | umls-concept:C0032743 | lld:lifeskim |
| pubmed-article:16896954 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:16896954 | lifeskim:mentions | umls-concept:C1512045 | lld:lifeskim |
| pubmed-article:16896954 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:16896954 | pubmed:dateCreated | 2006-8-23 | lld:pubmed |
| pubmed-article:16896954 | pubmed:abstractText | Atomoxetine is a potent and selective norepinephrine transporter (NET) reuptake inhibitor acting as a nonstimulant for the treatment of attention-deficit/hyperactivity disorder (ADHD). Previous positron emission tomography (PET) studies had failed to demonstrate the feasibility of measuring a dose-dependent and saturable NET occupancy in human brain using [11C]MeNER. | lld:pubmed |
| pubmed-article:16896954 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16896954 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16896954 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16896954 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16896954 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16896954 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16896954 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16896954 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16896954 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16896954 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16896954 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16896954 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:16896954 | pubmed:issn | 0033-3158 | lld:pubmed |
| pubmed-article:16896954 | pubmed:author | pubmed-author:HalldinChrist... | lld:pubmed |
| pubmed-article:16896954 | pubmed:author | pubmed-author:FardeLarsL | lld:pubmed |
| pubmed-article:16896954 | pubmed:author | pubmed-author:InnisRobert... | lld:pubmed |
| pubmed-article:16896954 | pubmed:author | pubmed-author:GulyásBalázsB | lld:pubmed |
| pubmed-article:16896954 | pubmed:author | pubmed-author:TauscherJohan... | lld:pubmed |
| pubmed-article:16896954 | pubmed:author | pubmed-author:VandenhendeFr... | lld:pubmed |
| pubmed-article:16896954 | pubmed:author | pubmed-author:VarroneAndrea... | lld:pubmed |
| pubmed-article:16896954 | pubmed:author | pubmed-author:SchouMagnusM | lld:pubmed |
| pubmed-article:16896954 | pubmed:author | pubmed-author:SenecaNichola... | lld:pubmed |
| pubmed-article:16896954 | pubmed:author | pubmed-author:AiraksinenAnu... | lld:pubmed |
| pubmed-article:16896954 | pubmed:author | pubmed-author:KielbasaWilli... | lld:pubmed |
| pubmed-article:16896954 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16896954 | pubmed:volume | 188 | lld:pubmed |
| pubmed-article:16896954 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16896954 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16896954 | pubmed:pagination | 119-27 | lld:pubmed |
| pubmed-article:16896954 | pubmed:meshHeading | pubmed-meshheading:16896954... | lld:pubmed |
| pubmed-article:16896954 | pubmed:meshHeading | pubmed-meshheading:16896954... | lld:pubmed |
| pubmed-article:16896954 | pubmed:meshHeading | pubmed-meshheading:16896954... | lld:pubmed |
| pubmed-article:16896954 | pubmed:meshHeading | pubmed-meshheading:16896954... | lld:pubmed |
| pubmed-article:16896954 | pubmed:meshHeading | pubmed-meshheading:16896954... | lld:pubmed |
| pubmed-article:16896954 | pubmed:meshHeading | pubmed-meshheading:16896954... | lld:pubmed |
| pubmed-article:16896954 | pubmed:meshHeading | pubmed-meshheading:16896954... | lld:pubmed |
| pubmed-article:16896954 | pubmed:meshHeading | pubmed-meshheading:16896954... | lld:pubmed |
| pubmed-article:16896954 | pubmed:meshHeading | pubmed-meshheading:16896954... | lld:pubmed |
| pubmed-article:16896954 | pubmed:meshHeading | pubmed-meshheading:16896954... | lld:pubmed |
| pubmed-article:16896954 | pubmed:meshHeading | pubmed-meshheading:16896954... | lld:pubmed |
| pubmed-article:16896954 | pubmed:meshHeading | pubmed-meshheading:16896954... | lld:pubmed |
| pubmed-article:16896954 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16896954 | pubmed:articleTitle | Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2. | lld:pubmed |
| pubmed-article:16896954 | pubmed:affiliation | Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institutet, Karolinska Hospital, S-17176, Stockholm, Sweden. Nicholasseneca@mail.nih.gov | lld:pubmed |
| pubmed-article:16896954 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16896954 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:16896954 | pubmed:publicationType | Research Support, N.I.H., Intramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16896954 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16896954 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16896954 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16896954 | lld:pubmed |
